Status:
TERMINATED
HPV Vaccination in Special Risk Groups: 5 Year Follow-up
Lead Sponsor:
Murdoch Childrens Research Institute
Collaborating Sponsors:
Monash Medical Centre
Conditions:
PRD (Paediatric Rheumatological Disease)
IBD (Inflammatory Bowel Disease)
Eligibility:
FEMALE
12-26 years
Brief Summary
In 2007-2009 the investigators conducted a study to determine the immunogenicity response to HPV vaccine in special risk patients known to be at increased risk of abnormal cervical cytology. The serol...
Detailed Description
This study is an open interventional study based at two paediatric tertiary centres in Melbourne, Australia. It is specifically looking at the long term immunogenic response to the 4 valent HPV vaccin...
Eligibility Criteria
Inclusion
- Females who participated in the initial HPV vaccine immunogenicity study in 2007.
Exclusion
- Inability to provide informed consent
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2012
Estimated Enrollment :
37 Patients enrolled
Trial Details
Trial ID
NCT01896986
Start Date
March 1 2012
End Date
March 1 2012
Last Update
June 15 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Childrens Hospital
Melbourne, Victoria, Australia, 2106